MAPK phosphatase DUSP16/MKP-7, a candidate tumor suppressor for chromosome region 12p12–13, reduces BCR-ABL-induced transformation
- 30 October 2003
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 22 (49), 7728-7736
- https://doi.org/10.1038/sj.onc.1207089
Abstract
Recurrent chromosome 12p deletions are associated with distinct tumor types and suggest the presence of a tumor suppressor gene (TSG). Previously, we mapped an EST with similarity to a protein tyrosine phosphatase to the minimally deleted region for all these neoplasms. The corresponding gene, DUSP16/MKP-7, was recently shown to code for a mitogen-activated protein kinase phosphatase, suggestive for a function as tumor suppressor. Overexpression of DUSP16 in BCR-ABL-transformed Rat-1 fibroblasts reduces their transforming capacity in vitro and in vivo via downregulation of BCR-ABL-induced JNK activation. A role for DUSP16 as a regulator of JNK signaling was further demonstrated via overexpression in Ba/F3 cells, which increased their antiapoptosis. However, no inactivating mutations could be detected in leukemia patients hemizygous for DUSP16, and the effect of hemizygosity on DUSP16 expression level could not be assessed due to the variability of DUSP16 transcript levels observed in leukaemia cell lines and in patients. Taken together, the functional data point to a context-dependent role for DUSP16 on cell transformation and apoptosis, reflecting the dual role of JNK, and therefore suggest that DUSP16 might be haploinsufficient for tumor suppression.Keywords
This publication has 38 references indexed in Scilit:
- A detailed transcriptional map of the chromosome 12p12 tumour suppressor locusEuropean Journal of Human Genetics, 2002
- MKP-7, a Novel Mitogen-activated Protein Kinase Phosphatase, Functions as a Shuttle ProteinJournal of Biological Chemistry, 2001
- A Novel MAPK Phosphatase MKP-7 Acts Preferentially on JNK/SAPK and p38α and β MAPKsJournal of Biological Chemistry, 2001
- 12p12‐13 deletion in prostate tumors and quantitative expression of CDKN1B and ETV6 candidate genesGenes, Chromosomes and Cancer, 2001
- Recurrent molecular deletion of the 12p13 region, centromeric to ETV6/TEL, in T-cell prolymphocytic leukemiaThe Hematology Journal, 2000
- JNK Activation Is Required for JB6 Cell Transformation Induced by Tumor Necrosis Factor-α but Not by 12-O-Tetradecanoylphorbol-13-AcetatePublished by Elsevier ,1999
- A Physical, Transcript, and Deletion Map of Chromosome Region 12p12.3 Flanked byETV6andCDKN1B:Hypermethylation of theLRP6CpG Island in Two Leukemia Patients with Hemizygous del(12p)Genomics, 1999
- Genomic Organization and Chromosomal Localization of a Member of the MAP Kinase Phosphatase Gene Family to Human Chromosome 11p15.5 and a Pseudogene to 10q11.2Genomics, 1997
- The ETV6, CDKN1B and D12S178 loci are involved in a segment commonly deleted in various 12p aberrations in different hematological malignanciesCytogenetic and Genome Research, 1996
- IL3-dependent mouse clones that express B-220 surface antigen, contain ig genes in germ-line configuration, and generate B lymphocytes in vivoCell, 1985